Apella Capital, LLC Merck & Co., Inc. Transaction History

Apella Capital, LLC

$2.41 Billion
Q3 2024

A detailed history of Apella Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Apella Capital, LLC holds 9,047 shares of MRK stock, worth $889,953. This represents 0.04% of its overall portfolio holdings.

Number of Shares

9,047

Previous 8,003 13.05%

Holding current value

$889,953

Previous $990,000 3.74%

% of portfolio

0.04%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$111.15 - $128.97 $116,040 - $134,644	1,044 Added 13.05%	9,047 $1.03 Million
Q2 2024 Jul 10, 2024	BUY	$123.8 - $132.96 $228,534 - $245,444	1,846 Added 29.98%	8,003 $990,000
Q1 2024 Apr 10, 2024	BUY	$113.24 - $131.95 $40,653 - $47,370	359 Added 6.19%	6,157 $812,000
Q4 2023 Jan 05, 2024	SELL	$100.18 - $109.02 $13,323 - $14,499	-133 Reduced 2.24%	5,798 $632,000
Q3 2023 Oct 10, 2023	BUY	$102.95 - $114.33 $26,355 - $29,268	256 Added 4.51%	5,931 $610,000
Q2 2023 Jul 06, 2023	SELL	$108.61 - $118.38 $75,918 - $82,747	-699 Reduced 10.97%	5,675 $654,000
Q4 2022 Jan 10, 2023	BUY	$87.44 - $112.11 $149,085 - $191,147	1,705 Added 36.52%	6,374 $0
Q3 2022 Oct 11, 2022	BUY	$84.53 - $94.96 $20,878 - $23,455	247 Added 5.59%	4,669 $402,000
Q2 2022 Jul 08, 2022	BUY	$83.49 - $94.64 $7,597 - $8,612	91 Added 2.1%	4,422 $403,000
Q1 2022 Apr 11, 2022	BUY	$73.51 - $82.4 $6,174 - $6,921	84 Added 1.98%	4,331 $355,000
Q4 2021 Jan 13, 2022	SELL	$72.28 - $90.54 $50,596 - $63,378	-700 Reduced 14.15%	4,247 $325,000
Q3 2021 Jan 18, 2022	BUY	$71.68 - $78.83 $15,339 - $16,869	214 Added 4.52%	4,947 $372,000
Q3 2021 Oct 12, 2021	SELL	$71.68 - $78.83 $102,144 - $112,332	-1,425 Reduced 23.14%	4,733 $386,000
Q2 2021 Jan 18, 2022	BUY	$70.31 - $77.77 $22,499 - $24,886	320 Added 5.48%	6,158 $479,000
Q2 2021 Jul 02, 2021	SELL	$70.31 - $77.77 $76,637 - $84,769	-1,090 Reduced 15.73%	5,838 $454,000
Q1 2021 Apr 15, 2021	SELL	$68.86 - $81.11 $82,356 - $97,007	-1,196 Reduced 14.72%	6,928 $534,000
Q4 2020 Feb 18, 2021	SELL	$71.77 - $79.65 $23,755 - $26,364	-331 Reduced 3.91%	8,124 $665,000
Q3 2020 Oct 22, 2020	BUY	$73.18 - $82.95 $31,101 - $35,253	425 Added 5.29%	8,455 $701,000
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $508,780 - $705,194	8,030 New	8,030 $618,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.

Account

Apella Capital, LLC Merck & Co., Inc. Transaction History